Hartford多因子小型股ETF ROSC 深 滬
已收盤 04-02 16:00:00 美东时间
48.8661
+0.182
+0.37%
華盛通- 最 高48.8661
- 今 開48.78
- 成交量 615股
- 最 低 48.78
- 昨 收 48.6838
- 總市值 5008.78万
- 52周最高 51.2029
- 市盈率 靜 --
- 換手率 0.06%
- 52周最低 36.1898
- 委 比 0.00%
- 總股本 102.50万
- 歷史最高 51.2029
- 量 比 0.45
- 振 幅 0.18%
- 歷史最低 12.8052
- 每 手 1
- 風險率 3.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Adobe Taps Nvidia AI Muscle To Revolutionize Marketing, Creative Pipelines
Adobe and Nvidia partner to launch next-gen Firefly models and agentic workflows, revolutionizing AI-powered creative and marketing tools.
03-17 18:22
BRIEF-Alto Neuroscience Announces $120 Million Private Placement Financing
BRIEF-Alto Neuroscience Announces $120 Million Private Placement Financing March 16 (Reuters) - Alto Neuroscience Inc ANRO.N : ALTO NEUROSCIENCE ANNOUNCES $120 MILLION PRIVATE PLACEMENT FINANCING ALTO NEUROSCIENCE - TO USE PROCEEDS TO SUPPORT DEVELOPMENT OF ALTO-207 IN TREATMENT RESISTANT DEPRESSION
03-16 19:40
BRIEF-Alto Neuroscience Reports Full Year 2025 Financial Results And Recent Business Highlights
BRIEF-Alto Neuroscience Reports Full Year 2025 Financial Results And Recent Business Highlights March 16 (Reuters) - Alto Neuroscience Inc ANRO.N : ALTO NEUROSCIENCE REPORTS FULL YEAR 2025 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS Source text: ID:nBwnw9Lra Further company coverage: ANRO.N (((
03-16 18:35
Adobe Hit With $150 Million Settlement For Trapping Users In Subscription Hell
Adobe (ADBE) beats Q1 earnings but faces $150M settlement and CEO transition. Is the stock a buy near 52-week lows? Read our analysis.
03-16 18:00
Adobe inks $150M deal with U.S. to resolve allegations over subscription practices
Adobe (ADBE) has reached a $150M settlement with the U.S. Justice Department to resolve allegations that the software maker concealed important information about its subscription plans, causing custom...
03-15 00:33
BRIEF-Klotho Neurosciences Acquires Greenland Mines Corp., Securing Control Of A $68 Billion Palladium, Gold, Platinum, And Critical Mineral Deposit In The World's Most Strategically Vital Emerging Trade Corridor
BRIEF-Klotho Neurosciences Acquires Greenland Mines Corp., Securing Control Of A $68 Billion Palladium, Gold, Platinum, And Critical Mineral Deposit In The World's Most Strategically Vital Emerging Trade Corridor March 4 (Reuters) - Klotho Neurosciences Inc KLTO.O : KLOTHO NEUROSCIENCES ACQUIRES GRE
03-04 21:01
BRIEF-Abbvie Announces $380 Million Investments In North Chicago
BRIEF-Abbvie Announces $380 Million Investments In North Chicago Feb 23 (Reuters) - Abbvie Inc ABBV.N : ABBVIE TO INVEST $380 MILLION IN NORTH CHICAGO TO FURTHER EXPAND ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURING IN THE UNITED STATES ABBVIE - TO HIRE 300 PEOPLE IN NORTH CHICAGO ABBVIE - CONSTRUCT
02-24 00:02
BRIEF-Firefly Neuroscience Inc May Offer, Sell Shares Of Common Stock Of Up To $7.4 Million From Time To Time
BRIEF-Firefly Neuroscience Inc May Offer, Sell Shares Of Common Stock Of Up To $7.4 Million From Time To Time Firefly Neuroscience Inc AIFF.O : FIREFLY NEUROSCIENCE INC: MAY OFFER, SELL SHARES OF COMMON STOCK OF UP TO $7.4 MILLION FROM TIME TO TIME Source text: [ID:n0001213900-26-011524] Further com
02-04 07:29
BRIEF-Jupiter Neurosciences Expands Nugevia Addressable Market with Focus on GLP-1 Users
BRIEF-Jupiter Neurosciences Expands Nugevia Addressable Market with Focus on GLP-1 Users Jan 28 (Reuters) - Jupiter Neurosciences Inc JUNS.O : JUPITER NEUROSCIENCES INC - ANNOUNCES STRATEGIC INITIATIVE FOR GLP-1 USERS Source text: ID:nGNX8RPntl Further company coverage: JUNS.O (( Reuters.Briefs@thom
01-28 19:02
BRIEF-Promis Neurosciences Exceeds Target Enrollment In Precise-Ad Phase 1B Cli Trial
Dec 18 (Reuters) - ProMIS Neurosciences Inc PMN.O: PROMIS NEUROSCIENCES EXCEEDS TARGET ENROLLMENT IN PRECISE-AD PHASE 1B CLINICAL TRIAL OF PMN310 IN ALZHEIMER’S DISEASE PROMIS NEUROSCIENCES INC - INTE...
2025-12-18 20:39
